Pharmacyclics, Inc. (PCYC) Blows Up Q2 Views, Posts Surprise Profit
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Join SI Premium – FREE
Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q2 EPS of $0.82, $1.00 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $77.9 million versus the consensus estimate of $2.64 million.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- FS Bancorp (FSBW) Misses Q3 EPS by 48c
- Lake Shore Bancorp (LSBK) Tops Q3 EPS by 31c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
